A Big Impact: Trends Shaping Small-Molecule APIs, Excipients, and Formulations
Webcasts
Webinar Date/Time: Thursday, September 21, 2023 at 11am ET | 10am CT | 8am PT | 4 pm BST
Learn about the biggest trends impacting small-molecule APIs, excipients, and formulations, key sessions to attend while at CPHI, innovations and novel approaches for pediatric dosage forms and taste-masking, and fundamental aspects of API manufacturing and distribution from a panel of experts who have contributed to this year’s CPHI Annual Report, David Tisi from Synopsys, and an SME from C2 Pharma in this episode of the PharmTech Drug Digest Video Series.
Register Free: https://www.pharmtech.com/pt_w/big-impact
Event Overview:
In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews experts about small-molecule APIs, excipients, and formulation advances. During the video session, a panel of experts—Bikash Chatterjee, Tara Dougal —deliberate on the biggest trends impacting the industry, highlighting issues such as API supply and shortages, uptake in digital innovations, formulation advances to deal with potent compounds, and key sessions to visit while at CPHI. Additionally, David Tisi, director of Technical Operations, Synopsys, discusses novel approaches and solutions to pediatric formulations and taste-masking, while an expert from C2 Pharma highlights the fundamental stages of gaining a certificate of suitability for APIs and the various trends shaping API and complex compound manufacturing.
Interviews featuring:
- Panel of experts from CPHI Annual Report
- Bikash Chatterjee, president and chief science officer at PharmTech Associates
- Tara Dougal, content director—Pharma, Informa Markets
- David Tisi
- Tara Fitzpatrick, head of Quality, C2 Pharma
This episode of Drug Digest is sponsored by:
- Actylis
- Adare Pharma Solutions
- Lonza
- Catalent Pharma Solutions
- Experic
- BioVectra DCL
- Societal CDMO
Key Learning Objectives
- Trends impacting small-molecule APIs, excipients, and formulation markets.
- Innovations benefitting API and excipient developers and formulation scientists.
- Novel approaches to pediatric formulations.
- Taste-masking solutions.
- Fundamental stages of gaining a certificate of suitability.
- Key sessions to visit while at CPHI.
Who Should Attend
- CDMOs
- Formulation scientists
- API developers and manufacturers
- Excipient developers and manufacturers
- Ingredients developers and manufacturers
- Process development experts
- Small-molecule development experts
- CPHI attendees
Speakers:
David Tisi
Director of Technical Operations
Synopsys
Tara Fitzpatrick
Head of Quality
C2 Pharma
Register Free: https://www.pharmtech.com/pt_w/big-impact
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
